Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Market Insights | US | 2018

The mature US CRM device market will remain flat through 2026, striking a balance between flat generator unit sales, rising ICM procedure volumes, and price erosion. Premium-priced devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs will help mitigate price erosion to a small extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the US cardiac rhythm management device market across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe (Supplemental)
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices | Market Insights | Europe | 2024
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs…